drugset / Trial / NCT05981976
A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy Participants
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the relative absorption of abatacept in healthy participants following subcutaneous (SC) administration in which the drug substance is manufactured with the current or new process.
Timeline
- Start
- 2023-08-18
- Primary completion
- 2023-12-14
- Completion
- 2023-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abatacept | Other / unclassified | — | Subcutaneous |
Indications
No indication recorded.